acut
exacerb
sourc
substanti
asthma
healthcar
cost
sever
asthma
exacerb
may
life
threaten
report
averag
cost
patient
acut
exacerb
time
higher
patient
without
one
although
multipl
factor
allergen
exposur
infect
air
pollut
medic
weather
chang
report
involv
asthma
exacerb
viral
respiratori
tract
infect
consid
common
trigger
one
studi
detect
respiratori
virus
adult
asthma
patient
acut
exacerb
studi
nonhospit
asthma
exacerb
children
report
presenc
viral
respiratori
ill
associ
sever
asthma
symptom
impact
recoveri
time
howev
inconsist
differ
studi
report
corn
report
studi
peopl
atop
asthma
sever
longerlast
lowerrespiratorytract
symptom
healthi
individu
purpos
current
studi
explor
preval
potenti
role
viral
respiratori
tract
infect
trigger
asthma
exacerb
use
subject
outpati
clinic
subject
stabl
asthma
experienc
asthma
exacerb
recruit
outpati
clinic
emerg
depart
first
affili
hospit
guangzhou
medic
univers
februari
februari
inclus
criteria
follow
diagnosi
asthma
confirm
clinic
profil
spirometri
result
accord
criteria
describ
global
initi
asthma
gina
guidelin
ii
age
year
iii
agre
provid
inform
consent
particip
studi
exclus
criteria
follow
major
system
disord
respiratori
disord
asthma
chronic
obstruct
pulmonari
diseas
bronchiectasi
ii
histori
psychiatr
disord
alcohol
drug
abus
persist
use
blocker
iii
disord
result
wheez
agematch
healthi
volunt
respiratori
symptom
within
previou
week
also
recruit
member
control
group
period
februari
februari
prospect
control
observ
studi
employ
compar
asthma
exacerb
viralposit
subject
viralneg
subject
estim
number
subject
need
studi
calcul
assum
viralposit
rate
would
subject
asthma
exacerb
subject
stabl
asthma
alpha
set
estim
number
requir
subject
case
presenc
respiratori
virus
nasal
swab
sampl
detect
taqman
realtim
polymeras
chain
reaction
pcr
asthma
symptom
score
assess
asthma
control
questionnair
acq
asthma
control
test
act
miniasthma
qualiti
life
questionnair
miniaqlq
pulmonari
function
assess
spirometri
symptom
fever
headach
myalgia
pharyngalgia
nasal
discharg
sneez
cough
dyspnea
night
waken
also
record
evalu
arbitrari
unit
null
sever
manag
asthma
exacerb
subject
consist
gina
recommend
patient
follow
week
asthma
diari
peak
expiratori
flow
pef
monitor
end
followup
patient
reevalu
viral
detect
spirometri
studi
approv
ethic
committe
statist
analys
perform
use
statist
product
servic
solut
spss
ibm
packag
normal
distribut
data
compar
ttest
express
mean
standard
deviat
sd
signific
chang
pair
data
analyz
pair
ttest
skew
data
analyz
mannwhitney
u
test
wilcoxon
sign
rank
test
express
median
interquartil
rang
twotail
p
valu
less
consid
signific
total
subject
asthma
exacerb
exacerb
group
subject
stabl
asthma
stabl
group
recruit
februari
februari
total
agematch
normal
volunt
recruit
control
normal
group
exacerb
group
initi
nasal
swab
obtain
averag
number
day
exacerb
onset
sampl
collect
rang
day
exacerb
group
case
complet
followup
followup
nasal
swab
sampl
use
viral
detect
nasal
swab
sampl
obtain
viral
detect
stabl
asthma
group
patient
normal
control
group
patient
demograph
data
stabl
exacerb
asthma
group
shown
tabl
exacerb
group
acq
act
score
higher
p
rate
inhal
corticosteroid
ic
mainten
therapi
lower
stabl
group
vs
p
signific
differ
durat
asthma
histori
smoke
statu
comorbid
rhiniti
stabl
exacerb
group
p
presenc
respiratori
virus
patient
sampl
detect
pcr
tabl
viralposit
rate
sampl
exacerb
group
significantli
higher
sampl
stabl
asthma
group
normal
control
group
p
signific
differ
viralposit
rate
stabl
control
group
test
virus
common
viral
yield
hcov
eight
case
flu
six
case
rsv
five
case
rv
four
case
hpiv
three
case
exacerb
group
sampl
six
case
posit
one
viru
accord
pcr
result
human
metapneumoviru
human
bocaviru
detect
sampl
among
viralposit
subject
viral
load
number
viral
copi
significantli
higher
acut
asthma
exacerb
group
signific
differ
found
virusposit
virusneg
subject
within
asthma
exacerb
group
p
sever
exacerb
act
score
acq
score
miniaqlq
score
gener
symptom
score
upper
respiratori
tract
symptom
score
lower
respiratori
tract
symptom
score
although
smoke
rate
higher
viralposit
subgroup
viralneg
subgroup
tabl
dynam
symptom
chang
observ
period
shown
figur
comparison
viralneg
subgroup
cough
score
viralposit
subgroup
asthma
exacerb
significantli
higher
day
patient
asthma
exacerb
complet
followup
lung
function
recoveri
exacerb
subject
shown
tabl
differ
recoveri
lung
function
viralposit
viralneg
subgroup
although
pef
monitor
meant
includ
studi
subject
actual
perform
coinfect
one
viru
detect
pcr
polymeras
chain
reaction
pef
monitor
perform
pef
monitor
poor
complianc
protocol
common
unabl
includ
pef
data
analys
posit
rate
respiratori
viral
detect
subject
similar
previou
report
literatur
type
studi
use
reliabl
methodolog
detect
respiratori
virus
crucial
previou
report
indic
pcr
method
use
detect
common
respiratori
virus
good
sensit
good
specif
recommend
first
choic
clinic
diagnosi
therefor
use
pcr
respiratori
viru
detect
studi
although
origin
plan
includ
detect
convalesc
antibodi
viru
cultur
studi
protocol
fail
acquir
convalesc
blood
sampl
major
patient
owe
low
complianc
rate
followup
clinic
visit
week
exacerb
addit
viru
cultur
well
known
low
yield
rate
recommend
routin
method
clinic
detect
import
factor
asthma
exacerb
induc
respiratori
virus
ident
number
viral
speci
involv
varieti
virus
might
involv
exacerb
asthma
sever
report
show
viral
infect
import
trigger
asthma
exacerb
includ
five
six
viral
speci
aim
includ
mani
respiratori
virus
possibl
detect
differ
viral
speci
sampl
agreement
previou
report
commonli
detect
virus
studi
influenza
influenza
b
human
parainfluenza
viru
rsv
human
coronaviru
rhinoviru
although
human
metapneumoviru
commonli
detect
asthma
exacerb
children
fail
find
human
metapneumoviru
cohort
subject
remain
controversi
whether
posit
pcr
result
alway
repres
true
respiratori
viral
infect
could
result
bystand
viru
address
issu
includ
stabl
asthma
healthi
subject
control
group
studi
although
respiratori
virus
detect
pcr
approxim
stabl
asthma
healthi
subject
viralposit
rate
significantli
higher
asthma
exacerb
group
signific
differ
rate
stabl
asthma
healthi
control
group
result
similar
report
corn
et
al
furthermor
result
use
quantit
pcr
method
show
viral
load
viral
copi
number
significantli
higher
exacerb
group
stabl
group
studi
still
need
establish
cutoff
valu
discrimin
true
infect
bystand
virus
asthma
patient
predispos
infect
respiratori
virus
epithelia
damag
caus
uncontrol
asthma
make
suscept
infect
use
ic
restor
intact
epithelia
reduc
incid
respiratori
viral
infect
one
report
indic
lack
ic
mainten
therapi
risk
factor
respiratori
infect
asthma
patient
consist
result
studi
addit
smoke
shown
anoth
import
risk
suscept
respiratori
viral
infect
especi
rhinoviru
infect
also
consist
result
impact
viral
infect
asthma
exacerb
remain
import
issu
interestingli
report
viral
infect
interact
allergen
exposur
trigger
asthma
exacerb
duff
et
al
report
coexist
high
ige
level
rhinoviru
infect
increas
risk
asthma
exacerb
odd
ratio
allergen
exposur
may
increas
express
intercellular
adhes
cell
surfac
receptor
rhinoviru
facilit
entri
howev
rhinoviru
infect
shown
promot
airway
hypersensit
eosinophil
neutrophil
lymphocyt
inflamm
ovalbuminsensit
mous
model
studi
messag
et
al
found
rhinoviru
infect
asthma
patient
increas
asthma
symptom
airway
eosinophil
inflamm
howev
studi
agre
similar
report
hongkong
signific
differ
viralposit
viralneg
asthma
exacerb
subgroup
overal
asthma
sever
cat
score
respiratori
symptom
first
visit
acut
exacerb
reason
discrep
unclear
could
includ
differ
studi
popul
studi
includ
asthma
exacerb
could
manag
outpati
clinic
includ
hospit
patient
whether
respiratori
viral
infect
import
asthma
exacerb
requir
hospit
children
still
remain
unknown
howev
studi
found
cough
symptom
promin
persist
viralposit
subgroup
viralneg
subgroup
indic
respiratori
viral
infect
impact
asthma
exacerb
investig
potenti
role
respiratori
viral
infect
asthma
exacerb
conduct
larger
sampl
size
patient
sever
asthma
exacerb
patient
prone
infect
respiratori
virus
children
elderli
respiratori
virus
detect
asthma
patient
experienc
acut
exacerb
patient
infect
virus
promin
persist
cough
symptom
suggest
respiratori
virus
involv
acut
exacerb
asthma
potenti
effect
respiratori
viral
infect
sever
asthma
exacerb
asthma
children
elderli
deserv
studi
